http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4119729-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc04f5c89d8c275354dbd39188a766ff |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 |
| filingDate | 1977-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1978-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ac5d1a7d9982aecdcb9ee8249603868 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_971a89cb21fd21e5076d135ac6d507c4 |
| publicationDate | 1978-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4119729-A |
| titleOfInvention | Alkylsulfonylphenoxypropanolamine therapeutic process |
| abstract | A new class of phenoxypropanolamine alkylsulfonyl derivatives and methods for their preparation are described. The new compounds possess antiarrhythmic and/or cardioselective beta -adrenergic blocking properties and are useful in the treatment of hypertension. Representative embodiments of the invention are 1-(isopropylamino)-3-[4-(methylsulfonyl)-m-tolyloxy]-2-propanol and 3-[4-(methylsulfonyl)-m-tolyloxy]-1-(1-phenoxy-2-propylamino)-2-propanol, the latter compound is particularly outstanding as an antihypertensive. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4880841-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5063246-A |
| priorityDate | 1975-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 501.